NasdaqGS:IBRXBiotechs
Has The Recent ImmunityBio Share Price Rebound Created An Opportunity In 2025?
Wondering if ImmunityBio at around $2.36 is a speculative trap or a misunderstood bargain? You are not alone, and that is exactly what this breakdown is here to unpack.
Despite a bruising longer term record, with the share price down about 17.8% over the last year and 63.4% over three years, the stock has shown signs of life recently, gaining roughly 3.1% in the past week and 14.6% over the last month, while still sitting 8.2% lower year to date.
Those moves have come as investors continue...